Condition (MeSH)
Nystagmus, Congenital
ClinicalTrials.gov lists 3 trials for Nystagmus, Congenital or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Nystagmus, Congenital itself; the rest are tagged with a narrower condition beneath it.
When did Nystagmus, Congenital trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2009 | 1 |
| 1999 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Nystagmus, Congenital trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Observational | 1 |
How many Nystagmus, Congenital trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 1 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Nystagmus, Congenital trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Merz Pharmaceuticals GmbH | 1 |
| National Eye Institute (NEI) | 1 |
Which publications cover Nystagmus, Congenital? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Crossed VEP asymmetry in a patient with AHR-linked infantile nystagmus and foveal hypoplasia. | Documenta ophthalmologica. Advances in ophthalmology | 2024 | Yes |
| Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA. | Investigative ophthalmology & visual science | 2009 | Yes |
| Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system. | Investigative ophthalmology & visual science | 2006 | Yes |
| Effects of extraocular muscle surgery on 15 patients with oculo-cutaneous albinism (OCA) and infantile nystagmus syndrome (INS). | American journal of ophthalmology | 2004 | Yes |
| Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2004 | Yes |
Showing 5 of 12 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.